Exelixis
EXEL
#1694
Rank
C$16.49 B
Marketcap
C$61.28
Share price
-0.02%
Change (1 day)
21.27%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Exelixis (EXEL) - Total assets

Total assets on the balance sheet as of September 2025 : C$3.90 Billion

According to Exelixis's latest financial reports the company's total assets are C$3.90 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Exelixis - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31C$4.22 B8.39%
2023-12-31C$3.90 B-6.36%
2022-12-31C$4.16 B25%
2021-12-31C$3.33 B22.35%
2020-12-31C$2.72 B10.66%
2019-12-31C$2.46 B27.12%
2018-12-31C$1.93 B135.16%
2017-12-31C$0.82 B2.91%
2016-12-31C$0.80 B73.65%
2015-12-31C$0.46 B22.89%
2014-12-31C$0.37 B-29.98%
2013-12-31C$0.53 B-25.29%
2012-12-31C$0.71 B79.25%
2011-12-31C$0.40 B10.92%
2010-12-31C$0.36 B-0.19%
2009-12-31C$0.36 B-26.01%
2008-12-31C$0.48 B18.78%
2007-12-31C$0.41 B-10.7%
2006-12-31C$0.46 B18.85%
2005-12-31C$0.38 B10.7%
2004-12-31C$0.34 B-24.61%
2003-12-31C$0.46 B-13.34%
2002-12-31C$0.53 B-3%
2001-12-31C$0.55 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
GlaxoSmithKline
GSK
C$113.91 B 2,820.45%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
C$210.43 B 5,294.77%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$178.96 B 4,488.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$133.85 B 3,331.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$124.52 B 3,092.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$266.37 B 6,728.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$288.36 B 7,292.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
C$38.18 M-99.02%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
C$0.13 B-96.41%๐Ÿ‡บ๐Ÿ‡ธ USA